Schulze Frank, Lang Annemarie, Schoon Janosch, Wassilew Georgi I, Reichert Johannes
Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Departments of Orthopaedic Surgery & Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Biomedicines. 2023 Jan 24;11(2):325. doi: 10.3390/biomedicines11020325.
Bone generally displays a high intrinsic capacity to regenerate. Nonetheless, large osseous defects sometimes fail to heal. The treatment of such large segmental defects still represents a considerable clinical challenge. The regeneration of large bone defects often proves difficult, since it relies on the formation of large amounts of bone within an environment impedimental to osteogenesis, characterized by soft tissue damage and hampered vascularization. Consequently, research efforts have concentrated on tissue engineering and regenerative medical strategies to resolve this multifaceted challenge. In this review, we summarize, critically evaluate, and discuss present approaches in light of their clinical relevance; we also present future advanced techniques for bone tissue engineering, outlining the steps to realize for their translation from bench to bedside. The discussion includes the physiology of bone healing, requirements and properties of natural and synthetic biomaterials for bone reconstruction, their use in conjunction with cellular components and suitable growth factors, and strategies to improve vascularization and the translation of these regenerative concepts to in vivo applications. We conclude that the ideal all-purpose material for scaffold-guided bone regeneration is currently not available. It seems that a variety of different solutions will be employed, according to the clinical treatment necessary.
骨骼通常表现出很高的内在再生能力。然而,大的骨缺损有时无法愈合。此类大段骨缺损的治疗仍然是一项相当大的临床挑战。大骨缺损的再生往往很困难,因为它依赖于在不利于骨生成的环境中形成大量骨组织,这种环境的特点是软组织损伤和血管化受阻。因此,研究工作集中在组织工程和再生医学策略上,以应对这一多方面的挑战。在这篇综述中,我们根据其临床相关性总结、批判性评估并讨论了目前的方法;我们还介绍了骨组织工程的未来先进技术,概述了将其从实验室转化到临床应用所需的步骤。讨论内容包括骨愈合的生理学、用于骨重建的天然和合成生物材料的要求及特性、它们与细胞成分和合适生长因子的联合使用,以及改善血管化的策略和将这些再生概念转化为体内应用的方法。我们得出结论,目前尚无用于支架引导骨再生的理想通用材料。根据所需的临床治疗,似乎将采用多种不同的解决方案。